Baudax Bio (BXRX) Peer Comparison

$0.01

$0.00 (0.00%)

As on 02-May-2024 09:30EDT

Market cap

$1 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Edit

	Baudax Bio (BXRX)	Qsam Biosciences Inc (QSAM)
Market cap ($ Mln)	1	37
Revenue ($ Mln)	0	--
Net Profit ($ Mln)	-7.15	-4.39
Net Margin (%)	-2,194.48	--
RoE (%)	--	1,617.91
Price to Earnings	--	--
Price-To-Book	0.68	201.64

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Baudax Bio (BXRX)	Qsam Biosciences Inc (QSAM)
Operating Revenue	0.33	0.00
Cost of Revenue	5.34	0.55
Gross Profit	-5.74	--
Operating Expenses	11.96	3.94
Operating Profit (EBIT)	-22.11	-3.94
Other Income	0.00	0.00
Profit before Tax	-25.71	-4.39
Provision for Tax	8.54	0.72
Profit after Tax (Net Income)	-7.15	-4.98
Minority Interest	0.00	0.00
Consolidated Profit	-24.00	-2.10

Liabilities ($ Mln)

	Baudax Bio (BXRX)	Qsam Biosciences Inc (QSAM)
Shareholder's Funds	-10.24	0.67
Minority Interest	0.00	0.00
Non-Current Liabilities	11.77	0.00
Current Liabilities	19.05	1.03
Total Liabilities	10.03	0.36

Assets ($ Mln)

	Baudax Bio (BXRX)	Qsam Biosciences Inc (QSAM)
Non-Current Assets	19.25	0.00
Current Assets	1.34	1.71
Total Assets	10.03	0.36
Total Debt*	8.10	0.01
Net Current Assets	-17.71	0.67

Cashflow ($ Mln)

	Baudax Bio (BXRX)	Qsam Biosciences Inc (QSAM)
Cash From Operating Activities	-27.79	-2.71
Cash Flow from Investing Activities	-0.02	--
Cash from Financing Activities	17.18	1.44
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Baudax Bio (BXRX)	Qsam Biosciences Inc (QSAM)
ROCE (%)	-2,537.55	-13,868.48
ROE (%)	1,067.45	1,294.60
ROA (%)	-18.25	-212.90
EBIT Margin (%)	-4,974.23	--
Net Margin (%)	-2,194.48	--
Cash Profit Margin (%)	-0.01	--

Growth Ratios

	Baudax Bio (BXRX)	Qsam Biosciences Inc (QSAM)
Revenue Growth (%)	-76.03	--
EBIT Growth (%)	-2.53	27.81
Net Profit Growth (%)	64.43	19.13
EPS Growth (%)	--	48.75
Book Value Growth (%)	--	130.99

Valuation Ratios

	Baudax Bio (BXRX)	Qsam Biosciences Inc (QSAM)
Price / Earnings	--	-1.41
Price / Book Value	--	-7.07
Dividend Yield (%)	--	--
EV/EBITDA	-0.15	-1.62
Market Cap ($ Cr)	--	--

Solvency Ratios

	Baudax Bio (BXRX)	Qsam Biosciences Inc (QSAM)
Debt to Equity	0.00	0.00
Short term debt to equity ratio	-0.54	0.01
Current Ratio	0.07	1.65
Quick Ratio	0.07	1.65
Interest Coverage	-0.49	-8.75

Operating Efficiency Ratios

	Baudax Bio (BXRX)	Qsam Biosciences Inc (QSAM)
Debtors to sales (%)	0.00	--
Asset Turnover	0.01	0.00
Receivable days	126.21	--
Inventory Days	130.33	--
Payable days	140.57	--
Cash Conversion Cycle	115.97	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly